CAMBRIDGE, Mass., Dec. 28, 2023. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that
Artificial intelligence (AI) holds the promise of identifying premalignant and advanced malignant lesions during colonoscopy that might otherwise be missed.
TOPLINE: ChatGPT offers mostly accurate insights into cardiac arrest, benefiting laypeople, but cardiopulmonary resuscitation (CPR)-related answers require improvement. METHODOLOGY: A